Skip to main content
Erschienen in: Inflammation 5/2022

23.04.2022 | Original Article

LncRNA FLG-AS1 Mitigates Diabetic Retinopathy by Regulating Retinal Epithelial Cell Inflammation, Oxidative Stress, and Apoptosis via miR-380-3p/SOCS6 Axis

verfasst von: Rong Luo, Lan Li, Fan Xiao, Jinsong Fu

Erschienen in: Inflammation | Ausgabe 5/2022

Einloggen, um Zugang zu erhalten

Abstract

The objective of this study is to investigate lncRNA FLG-AS1-mediated miR-380-3p/SOCS6 axis in inflammation, oxidative stress, and apoptosis of retinal epithelial cells in diabetic retinopathy (DR). Fasting blood was collected from 60 DR patients and 60 healthy controls. The Pearson correlation was used to analyze the correlation between the expression levels of FLG-AS1 and miR-380-3p in DR patients. qRT-PCR and/or Western blotting were used to detect the expression of FLG-AS1, miR-380-3p, and SOCS6. After gain of function of FLG-AS1 or SOCS6 or loss of function of miR-380-3p, high glucose (HG)–treated human retinal pigment epithelial ARPE-19 cells were subjected to TUNEL assessment of apoptosis. ELISA was performed to detect the expression levels of IL-1β, IL-6, and TNF-α in cell culture supernatant. DCFH-DA was used to detect the level of ROS in the cells. MDA and SOD assay kits were used to measure the activity of MDA and SOD in the cells. Dual-luciferase reporter assay was performed to verify the binding between miR-380-3p and FLG-AS1 or between miR-380-3p and SOCS6. Streptozotocin injections were used to induce diabetes in rats which were injected with FLG-AS1 overexpression lentiviral vectors in the eye. Twenty weeks later, retinal tissue was isolated and stained with hematoxylin–eosin or TUNEL. Compared to that in healthy controls, FLG-AS1 expression decreased 2.5-fold and miR-380-3p expression increased 2.6-fold in the serum of DR patients. The expression levels of FLG-AS1 and miR-380-3p were negatively correlated in DR patients (r = −0.3772, P = 0.003). Overexpression of FLG-AS1 reduced inflammation, oxidative stress, and apoptosis of HG-treated ARPE-19 cells and alleviated retinal injury in diabetic rats. FLG-AS1 promoted the expression of SOCS6 by targeting miR-380-3p. Inhibition of miR-380-3p or overexpression of SOCS6 reduced inflammation, oxidative stress, and apoptosis of HG-treated ARPE-19 cells. FLG-AS1 mitigates DR by regulating retinal epithelial cell inflammation, oxidative stress, and apoptosis via the miR-380-3p/SOCS6 axis.
Literatur
1.
Zurück zum Zitat Gargeya, R., and T. Leng. 2017. Automated Identification of Diabetic Retinopathy Using Deep Learning. Ophthalmology 124 (7): 962–969.CrossRef Gargeya, R., and T. Leng. 2017. Automated Identification of Diabetic Retinopathy Using Deep Learning. Ophthalmology 124 (7): 962–969.CrossRef
2.
Zurück zum Zitat Duh, E.J., J.K. Sun and A.W. Stitt. 2017. Diabetic retinopathy: current understanding, mechanisms, and treatment strategies. JCI Insight 2 (14). Duh, E.J., J.K. Sun and A.W. Stitt. 2017. Diabetic retinopathy: current understanding, mechanisms, and treatment strategies. JCI Insight 2 (14).
3.
Zurück zum Zitat Saeedi, P., I. Petersohn, P. Salpea, B. Malanda, S. Karuranga, N. Unwin, S. Colagiuri, et al. 2019. Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: results from the International Diabetes Federation Diabetes Atlas, 9(th) edition. Diabetes Research and Clinical Practice 157: 107843. Saeedi, P., I. Petersohn, P. Salpea, B. Malanda, S. Karuranga, N. Unwin, S. Colagiuri, et al. 2019. Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: results from the International Diabetes Federation Diabetes Atlas, 9(th) edition. Diabetes Research and Clinical Practice 157: 107843.
4.
Zurück zum Zitat Wong, T.Y., C.M. Cheung, M. Larsen, S. Sharma, and R. Simo. 2016. Diabetic retinopathy. Nature Reviews. Disease Primers 2: 16012.CrossRef Wong, T.Y., C.M. Cheung, M. Larsen, S. Sharma, and R. Simo. 2016. Diabetic retinopathy. Nature Reviews. Disease Primers 2: 16012.CrossRef
5.
Zurück zum Zitat Kusuhara, S., Y. Fukushima, S. Ogura, N. Inoue, and A. Uemura. 2018. Pathophysiology of diabetic retinopathy: The old and the new. Diabetes and Metabolism Journal 42 (5): 364–376.CrossRef Kusuhara, S., Y. Fukushima, S. Ogura, N. Inoue, and A. Uemura. 2018. Pathophysiology of diabetic retinopathy: The old and the new. Diabetes and Metabolism Journal 42 (5): 364–376.CrossRef
6.
Zurück zum Zitat Rubsam, A., S. Parikh and P.E. Fort. 2018. Role of inflammation in diabetic retinopathy. International Journal of Molecular Sciences 19 (4). Rubsam, A., S. Parikh and P.E. Fort. 2018. Role of inflammation in diabetic retinopathy. International Journal of Molecular Sciences 19 (4).
7.
Zurück zum Zitat Giurdanella, G., C.D. Anfuso, M. Olivieri, G. Lupo, N. Caporarello, C.M. Eandi, F. Drago, et al. 2015. Aflibercept, bevacizumab and ranibizumab prevent glucose-induced damage in human retinal pericytes in vitro, through a PLA2/COX-2/VEGF-A pathway. Biochemical Pharmacology 96 (3): 278–287.CrossRef Giurdanella, G., C.D. Anfuso, M. Olivieri, G. Lupo, N. Caporarello, C.M. Eandi, F. Drago, et al. 2015. Aflibercept, bevacizumab and ranibizumab prevent glucose-induced damage in human retinal pericytes in vitro, through a PLA2/COX-2/VEGF-A pathway. Biochemical Pharmacology 96 (3): 278–287.CrossRef
8.
Zurück zum Zitat Huang, Q., and J. Li. 2021. Research progress of lncRNAs in diabetic retinopathy. European Journal of Ophthalmology 31 (4): 1606–1617.CrossRef Huang, Q., and J. Li. 2021. Research progress of lncRNAs in diabetic retinopathy. European Journal of Ophthalmology 31 (4): 1606–1617.CrossRef
9.
Zurück zum Zitat Feng, L., J.R. Houck, P. Lohavanichbutr, and C. Chen. 2017. Transcriptome analysis reveals differentially expressed lncRNAs between oral squamous cell carcinoma and healthy oral mucosa. Oncotarget 8 (19): 31521–31531.CrossRef Feng, L., J.R. Houck, P. Lohavanichbutr, and C. Chen. 2017. Transcriptome analysis reveals differentially expressed lncRNAs between oral squamous cell carcinoma and healthy oral mucosa. Oncotarget 8 (19): 31521–31531.CrossRef
10.
Zurück zum Zitat Jiang, L., L. Hong, W. Yang, Y. Zhao, A. Tan, and Y. Li. 2019. Co-expression network analysis of the lncRNAs and mRNAs associated with cervical cancer progression. Archives of Medical Science 15 (3): 754–764.CrossRef Jiang, L., L. Hong, W. Yang, Y. Zhao, A. Tan, and Y. Li. 2019. Co-expression network analysis of the lncRNAs and mRNAs associated with cervical cancer progression. Archives of Medical Science 15 (3): 754–764.CrossRef
11.
Zurück zum Zitat Nie, K., Z. Deng, Z. Zheng, Y. Wen, J. Pan, X. Jiang, Y. Yan, et al. 2020. Identification of a 14-lncRNA signature and construction of a prognostic nomogram predicting overall survival of gastric cancer. DNA and Cell Biology 39 (9): 1532–1544.CrossRef Nie, K., Z. Deng, Z. Zheng, Y. Wen, J. Pan, X. Jiang, Y. Yan, et al. 2020. Identification of a 14-lncRNA signature and construction of a prognostic nomogram predicting overall survival of gastric cancer. DNA and Cell Biology 39 (9): 1532–1544.CrossRef
12.
Zurück zum Zitat Hu, W., Y. Ding, S. Wang, L. Xu, and H. Yu. 2020. The construction and analysis of the aberrant lncRNA-miRNA-mRNA network in adipose tissue from type 2 diabetes individuals with obesity. Journal of Diabetes Research 2020: 3980742.PubMedPubMedCentral Hu, W., Y. Ding, S. Wang, L. Xu, and H. Yu. 2020. The construction and analysis of the aberrant lncRNA-miRNA-mRNA network in adipose tissue from type 2 diabetes individuals with obesity. Journal of Diabetes Research 2020: 3980742.PubMedPubMedCentral
13.
Zurück zum Zitat Lu, T.X., and M.E. Rothenberg. 2018. MicroRNA. The Journal of Allergy and Clinical Immunology 141 (4): 1202–1207.CrossRef Lu, T.X., and M.E. Rothenberg. 2018. MicroRNA. The Journal of Allergy and Clinical Immunology 141 (4): 1202–1207.CrossRef
14.
Zurück zum Zitat Platania, C.B.M., R. Maisto, M.C. Trotta, M. D’Amico, S. Rossi, C. Gesualdo, G. D’Amico, et al. 2019. Retinal and circulating miRNA expression patterns in diabetic retinopathy: An in silico and in vivo approach. British Journal of Pharmacology 176 (13): 2179–2194.PubMedPubMedCentral Platania, C.B.M., R. Maisto, M.C. Trotta, M. D’Amico, S. Rossi, C. Gesualdo, G. D’Amico, et al. 2019. Retinal and circulating miRNA expression patterns in diabetic retinopathy: An in silico and in vivo approach. British Journal of Pharmacology 176 (13): 2179–2194.PubMedPubMedCentral
15.
Zurück zum Zitat Bali, K.K., J. Gandla, D.R. Rangel, L. Castaldi, P. Mouritzen, N. Agarwal, M. Schmelz, et al. 2021. A genome-wide screen reveals microRNAs in peripheral sensory neurons driving painful diabetic neuropathy. Pain 162 (5): 1334–1351.CrossRef Bali, K.K., J. Gandla, D.R. Rangel, L. Castaldi, P. Mouritzen, N. Agarwal, M. Schmelz, et al. 2021. A genome-wide screen reveals microRNAs in peripheral sensory neurons driving painful diabetic neuropathy. Pain 162 (5): 1334–1351.CrossRef
16.
Zurück zum Zitat Shan, T.D., H. Yue, X.G. Sun, Y.P. Jiang, and L. Chen. 2021. Rspo3 regulates the abnormal differentiation of small intestinal epithelial cells in diabetic state. Stem Cell Research & Therapy 12 (1): 330.CrossRef Shan, T.D., H. Yue, X.G. Sun, Y.P. Jiang, and L. Chen. 2021. Rspo3 regulates the abnormal differentiation of small intestinal epithelial cells in diabetic state. Stem Cell Research & Therapy 12 (1): 330.CrossRef
17.
Zurück zum Zitat Yuan, D., W. Wang, J. Su, Y. Zhang, B. Luan, H. Rao, T. Cheng, et al. 2018. SOCS6 functions as a tumor suppressor by inducing apoptosis and inhibiting angiogenesis in human prostate cancer. Current Cancer Drug Targets 18 (9): 894–904.CrossRef Yuan, D., W. Wang, J. Su, Y. Zhang, B. Luan, H. Rao, T. Cheng, et al. 2018. SOCS6 functions as a tumor suppressor by inducing apoptosis and inhibiting angiogenesis in human prostate cancer. Current Cancer Drug Targets 18 (9): 894–904.CrossRef
18.
Zurück zum Zitat Liu, Z., D. Xie, and H. Zhang. 2018. Long noncoding RNA neuroblastoma-associated transcript 1 gene inhibits malignant cellular phenotypes of bladder cancer through miR-21/SOCS6 axis. Cell Death & Disease 9 (10): 1042.CrossRef Liu, Z., D. Xie, and H. Zhang. 2018. Long noncoding RNA neuroblastoma-associated transcript 1 gene inhibits malignant cellular phenotypes of bladder cancer through miR-21/SOCS6 axis. Cell Death & Disease 9 (10): 1042.CrossRef
19.
Zurück zum Zitat Tan, J., L. Xiang, and G. Xu. 2019. LncRNA MEG3 suppresses migration and promotes apoptosis by sponging miR-548d-3p to modulate JAK-STAT pathway in oral squamous cell carcinoma. IUBMB Life 71 (7): 882–890.CrossRef Tan, J., L. Xiang, and G. Xu. 2019. LncRNA MEG3 suppresses migration and promotes apoptosis by sponging miR-548d-3p to modulate JAK-STAT pathway in oral squamous cell carcinoma. IUBMB Life 71 (7): 882–890.CrossRef
20.
Zurück zum Zitat Xiao, F., L. Li, J.S. Fu, Y.X. Hu and R. Luo. 2020. Regulation of the miR-19b-mediated SOCS6-JAK2/STAT3 pathway by lncRNA MEG3 is involved in high glucose-induced apoptosis in hRMECs. Bioscience Reports 40 (7). Xiao, F., L. Li, J.S. Fu, Y.X. Hu and R. Luo. 2020. Regulation of the miR-19b-mediated SOCS6-JAK2/STAT3 pathway by lncRNA MEG3 is involved in high glucose-induced apoptosis in hRMECs. Bioscience Reports 40 (7).
21.
Zurück zum Zitat Thomas, A.A., S. Biswas, B. Feng, S. Chen, J. Gonder, and S. Chakrabarti. 2019. lncRNA H19 prevents endothelial-mesenchymal transition in diabetic retinopathy. Diabetologia 62 (3): 517–530.CrossRef Thomas, A.A., S. Biswas, B. Feng, S. Chen, J. Gonder, and S. Chakrabarti. 2019. lncRNA H19 prevents endothelial-mesenchymal transition in diabetic retinopathy. Diabetologia 62 (3): 517–530.CrossRef
22.
Zurück zum Zitat Zhang, D., H. Qin, Y. Leng, X. Li, L. Zhang, D. Bai, Y. Meng, et al. 2018. LncRNA MEG3 overexpression inhibits the development of diabetic retinopathy by regulating TGF-beta1 and VEGF. Experimental and Therapeutic Medicine 16 (3): 2337–2342.PubMedPubMedCentral Zhang, D., H. Qin, Y. Leng, X. Li, L. Zhang, D. Bai, Y. Meng, et al. 2018. LncRNA MEG3 overexpression inhibits the development of diabetic retinopathy by regulating TGF-beta1 and VEGF. Experimental and Therapeutic Medicine 16 (3): 2337–2342.PubMedPubMedCentral
23.
Zurück zum Zitat Liu, P., S.B. Jia, J.M. Shi, W.J. Li, L.S. Tang, X.H. Zhu and P. Tong. 2019. LncRNA-MALAT1 promotes neovascularization in diabetic retinopathy through regulating miR-125b/VE-cadherin axis. Bioscience Reports 39 (5). Liu, P., S.B. Jia, J.M. Shi, W.J. Li, L.S. Tang, X.H. Zhu and P. Tong. 2019. LncRNA-MALAT1 promotes neovascularization in diabetic retinopathy through regulating miR-125b/VE-cadherin axis. Bioscience Reports 39 (5).
24.
Zurück zum Zitat Sun, Y., and Y.X. Liu. 2018. LncRNA HOTTIP improves diabetic retinopathy by regulating the p38-MAPK pathway. European Review for Medical and Pharmacological Sciences 22 (10): 2941–2948.PubMed Sun, Y., and Y.X. Liu. 2018. LncRNA HOTTIP improves diabetic retinopathy by regulating the p38-MAPK pathway. European Review for Medical and Pharmacological Sciences 22 (10): 2941–2948.PubMed
25.
Zurück zum Zitat Wu, J., Z. Chen, L. Zhang, J. Cao, X. Li, Z. Gong, H. Bo, et al. 2020. Knockdown of LINC01116 inhibits cell migration and invasion in head and neck squamous cell carcinoma through epithelial-mesenchymal transition pathway. Journal of Cellular Biochemistry 121 (1): 867–875.CrossRef Wu, J., Z. Chen, L. Zhang, J. Cao, X. Li, Z. Gong, H. Bo, et al. 2020. Knockdown of LINC01116 inhibits cell migration and invasion in head and neck squamous cell carcinoma through epithelial-mesenchymal transition pathway. Journal of Cellular Biochemistry 121 (1): 867–875.CrossRef
26.
Zurück zum Zitat Baurecht, H., M. Hotze, S. Brand, C. Buning, P. Cormican, A. Corvin, D. Ellinghaus, et al. 2015. Genome-wide comparative analysis of atopic dermatitis and psoriasis gives insight into opposing genetic mechanisms. American Journal of Human Genetics 96 (1): 104–120.CrossRef Baurecht, H., M. Hotze, S. Brand, C. Buning, P. Cormican, A. Corvin, D. Ellinghaus, et al. 2015. Genome-wide comparative analysis of atopic dermatitis and psoriasis gives insight into opposing genetic mechanisms. American Journal of Human Genetics 96 (1): 104–120.CrossRef
27.
Zurück zum Zitat Miller, J.E., M.K. Shivakumar, S.L. Risacher, A.J. Saykin, S. Lee, K. Nho, and D. Kim. 2018. Codon bias among synonymous rare variants is associated with Alzheimer’s disease imaging biomarker. Pacific Symposium on Biocomputing 23: 365–376.PubMed Miller, J.E., M.K. Shivakumar, S.L. Risacher, A.J. Saykin, S. Lee, K. Nho, and D. Kim. 2018. Codon bias among synonymous rare variants is associated with Alzheimer’s disease imaging biomarker. Pacific Symposium on Biocomputing 23: 365–376.PubMed
28.
Zurück zum Zitat Amadio, M., A. Pascale, S. Cupri, R. Pignatello, C. Osera, D.A. V, D.A. AG, et al. 2016. Nanosystems based on siRNA silencing HuR expression counteract diabetic retinopathy in rat. Pharmacological Research 111: 713–720.CrossRef Amadio, M., A. Pascale, S. Cupri, R. Pignatello, C. Osera, D.A. V, D.A. AG, et al. 2016. Nanosystems based on siRNA silencing HuR expression counteract diabetic retinopathy in rat. Pharmacological Research 111: 713–720.CrossRef
29.
Zurück zum Zitat Wu, X. 2020. Depletion of miR-380 mitigates human bronchial epithelial cells injury to improve chronic obstructive pulmonary disease through targeting CHRNA4. Molecular and Cellular Probes 49: 101492. Wu, X. 2020. Depletion of miR-380 mitigates human bronchial epithelial cells injury to improve chronic obstructive pulmonary disease through targeting CHRNA4. Molecular and Cellular Probes 49: 101492.
30.
Zurück zum Zitat Li, X., X. Lou, S. Xu, J. Du, and J. Wu. 2020. Hypoxia inducible factor-1 (HIF-1alpha) reduced inflammation in spinal cord injury via miR-380-3p/ NLRP3 by Circ 0001723. Biological Research 53 (1): 35.CrossRef Li, X., X. Lou, S. Xu, J. Du, and J. Wu. 2020. Hypoxia inducible factor-1 (HIF-1alpha) reduced inflammation in spinal cord injury via miR-380-3p/ NLRP3 by Circ 0001723. Biological Research 53 (1): 35.CrossRef
31.
Zurück zum Zitat Cai, Z., F. Zheng, Y. Ding, Y. Zhan, R. Gong, J. Li, M. Aschner, et al. 2019. Nrf2-regulated miR-380–3p blocks the translation of Sp3 protein and its mediation of paraquat-induced toxicity in mouse neuroblastoma N2a cells. Toxicological Sciences. Cai, Z., F. Zheng, Y. Ding, Y. Zhan, R. Gong, J. Li, M. Aschner, et al. 2019. Nrf2-regulated miR-380–3p blocks the translation of Sp3 protein and its mediation of paraquat-induced toxicity in mouse neuroblastoma N2a cells. Toxicological Sciences.
32.
Zurück zum Zitat Xia, Y., K. Wei, F.M. Yang, L.Q. Hu, C.F. Pan, X.L. Pan, W.B. Wu, et al. 2019. miR-1260b, mediated by YY1, activates KIT signaling by targeting SOCS6 to regulate cell proliferation and apoptosis in NSCLC. Cell Death & Disease 10 (2): 112.CrossRef Xia, Y., K. Wei, F.M. Yang, L.Q. Hu, C.F. Pan, X.L. Pan, W.B. Wu, et al. 2019. miR-1260b, mediated by YY1, activates KIT signaling by targeting SOCS6 to regulate cell proliferation and apoptosis in NSCLC. Cell Death & Disease 10 (2): 112.CrossRef
33.
Zurück zum Zitat Zhang, J., X.M. Pu, and Y. Xiong. 2019. kshv-mir-k12-1-5p promotes cell growth and metastasis by targeting SOCS6 in Kaposi’s sarcoma cells. Cancer Manag Res 11: 4985–4995.CrossRef Zhang, J., X.M. Pu, and Y. Xiong. 2019. kshv-mir-k12-1-5p promotes cell growth and metastasis by targeting SOCS6 in Kaposi’s sarcoma cells. Cancer Manag Res 11: 4985–4995.CrossRef
34.
Zurück zum Zitat Lei, Z., X. Tang, A. Si, P. Yang, L. Wang, T. Luo, G. Guo, et al. 2020. microRNA-454 promotes liver tumor-initiating cell expansion by regulating SOCS6. Experimental Cell Research 390 (1): 111955. Lei, Z., X. Tang, A. Si, P. Yang, L. Wang, T. Luo, G. Guo, et al. 2020. microRNA-454 promotes liver tumor-initiating cell expansion by regulating SOCS6. Experimental Cell Research 390 (1): 111955.
35.
Zurück zum Zitat Zhang, W., X. Li, Y. Tang, C. Chen, R. Jing, and T. Liu. 2020. miR-155-5p implicates in the pathogenesis of renal fibrosis via targeting SOCS1 and SOCS6. Oxidative Medicine and Cellular Longevity 2020: 6263921.PubMedPubMedCentral Zhang, W., X. Li, Y. Tang, C. Chen, R. Jing, and T. Liu. 2020. miR-155-5p implicates in the pathogenesis of renal fibrosis via targeting SOCS1 and SOCS6. Oxidative Medicine and Cellular Longevity 2020: 6263921.PubMedPubMedCentral
36.
Zurück zum Zitat Chen, H., Z. Lan, Q. Li, and Y. Li. 2019. Abnormal expression of long noncoding RNA FGD5-AS1 affects the development of periodontitis through regulating miR-142-3p/SOCS6/NF-kappaB pathway. Artificial Cells, Nanomedicine, and Biotechnology 47 (1): 2098–2106.CrossRef Chen, H., Z. Lan, Q. Li, and Y. Li. 2019. Abnormal expression of long noncoding RNA FGD5-AS1 affects the development of periodontitis through regulating miR-142-3p/SOCS6/NF-kappaB pathway. Artificial Cells, Nanomedicine, and Biotechnology 47 (1): 2098–2106.CrossRef
37.
Zurück zum Zitat Ge, X., P. Tang, Y. Rong, D. Jiang, X. Lu, C. Ji, J. Wang, et al. 2021. Exosomal miR-155 from M1-polarized macrophages promotes EndoMT and impairs mitochondrial function via activating NF-kappaB signaling pathway in vascular endothelial cells after traumatic spinal cord injury. Redox Biology 41: 101932. Ge, X., P. Tang, Y. Rong, D. Jiang, X. Lu, C. Ji, J. Wang, et al. 2021. Exosomal miR-155 from M1-polarized macrophages promotes EndoMT and impairs mitochondrial function via activating NF-kappaB signaling pathway in vascular endothelial cells after traumatic spinal cord injury. Redox Biology 41: 101932.
Metadaten
Titel
LncRNA FLG-AS1 Mitigates Diabetic Retinopathy by Regulating Retinal Epithelial Cell Inflammation, Oxidative Stress, and Apoptosis via miR-380-3p/SOCS6 Axis
verfasst von
Rong Luo
Lan Li
Fan Xiao
Jinsong Fu
Publikationsdatum
23.04.2022
Verlag
Springer US
Erschienen in
Inflammation / Ausgabe 5/2022
Print ISSN: 0360-3997
Elektronische ISSN: 1573-2576
DOI
https://doi.org/10.1007/s10753-022-01665-6

Weitere Artikel der Ausgabe 5/2022

Inflammation 5/2022 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Erhebliches Risiko für Kehlkopfkrebs bei mäßiger Dysplasie

29.05.2024 Larynxkarzinom Nachrichten

Fast ein Viertel der Personen mit mäßig dysplastischen Stimmlippenläsionen entwickelt einen Kehlkopftumor. Solche Personen benötigen daher eine besonders enge ärztliche Überwachung.

Nach Herzinfarkt mit Typ-1-Diabetes schlechtere Karten als mit Typ 2?

29.05.2024 Herzinfarkt Nachrichten

Bei Menschen mit Typ-2-Diabetes sind die Chancen, einen Myokardinfarkt zu überleben, in den letzten 15 Jahren deutlich gestiegen – nicht jedoch bei Betroffenen mit Typ 1.

15% bedauern gewählte Blasenkrebs-Therapie

29.05.2024 Urothelkarzinom Nachrichten

Ob Patienten und Patientinnen mit neu diagnostiziertem Blasenkrebs ein Jahr später Bedauern über die Therapieentscheidung empfinden, wird einer Studie aus England zufolge von der Radikalität und dem Erfolg des Eingriffs beeinflusst.

Costims – das nächste heiße Ding in der Krebstherapie?

28.05.2024 Onkologische Immuntherapie Nachrichten

„Kalte“ Tumoren werden heiß – CD28-kostimulatorische Antikörper sollen dies ermöglichen. Am besten könnten diese in Kombination mit BiTEs und Checkpointhemmern wirken. Erste klinische Studien laufen bereits.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.